IRIS
SOTA, JURGEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.375
EU - Europa 6.186
AS - Asia 4.687
SA - Sud America 893
Continente sconosciuto - Info sul continente non disponibili 430
AF - Africa 275
OC - Oceania 17
Totale 19.863
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.206
IT - Italia 1.582
RU - Federazione Russa 1.483
SG - Singapore 1.454
CN - Cina 1.243
GB - Regno Unito 1.137
BR - Brasile 719
VN - Vietnam 569
IE - Irlanda 528
HK - Hong Kong 357
FR - Francia 294
BD - Bangladesh 271
SE - Svezia 270
KR - Corea 249
DE - Germania 242
FI - Finlandia 176
UA - Ucraina 175
IN - India 148
ZA - Sudafrica 131
CA - Canada 85
TR - Turchia 84
NL - Olanda 63
AR - Argentina 57
IQ - Iraq 52
MX - Messico 49
JP - Giappone 45
PL - Polonia 45
PK - Pakistan 39
ES - Italia 32
EC - Ecuador 29
AT - Austria 27
BE - Belgio 26
KE - Kenya 26
CI - Costa d'Avorio 24
ID - Indonesia 23
CZ - Repubblica Ceca 22
MA - Marocco 22
VE - Venezuela 22
CO - Colombia 19
EG - Egitto 18
AU - Australia 17
SA - Arabia Saudita 17
IR - Iran 16
UZ - Uzbekistan 15
DZ - Algeria 14
NG - Nigeria 14
CL - Cile 13
NP - Nepal 13
PE - Perù 13
AE - Emirati Arabi Uniti 11
JO - Giordania 11
CR - Costa Rica 10
PH - Filippine 10
TN - Tunisia 10
JM - Giamaica 9
CH - Svizzera 8
LB - Libano 8
MY - Malesia 8
PY - Paraguay 8
DK - Danimarca 7
LT - Lituania 7
RO - Romania 7
AL - Albania 6
IL - Israele 6
UY - Uruguay 6
EE - Estonia 5
NO - Norvegia 5
RS - Serbia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
ET - Etiopia 4
GR - Grecia 4
HU - Ungheria 4
LV - Lettonia 4
GY - Guiana 3
MD - Moldavia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
CG - Congo 2
CY - Cipro 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
PA - Panama 2
SV - El Salvador 2
TG - Togo 2
TM - Turkmenistan 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
Totale 19.413
Salva come PNG Salva come JPEG
Città #
Dallas 1.205
Southend 965
Singapore 837
Dublin 517
Santa Clara 499
Ashburn 492
Milan 459
Moscow 415
Fairfield 405
San Jose 403
Hefei 380
Hong Kong 331
Council Bluffs 321
Beijing 258
Seoul 249
Woodbridge 227
Rome 189
Siena 189
New York 184
Houston 179
Chandler 178
Ho Chi Minh City 178
Menlo Park 176
Los Angeles 172
Wilmington 154
Ann Arbor 150
Seattle 147
Cambridge 138
Jacksonville 138
Hanoi 136
The Dalles 136
Lauterbourg 127
Johannesburg 118
Helsinki 105
Princeton 85
Munich 83
São Paulo 66
Buffalo 63
Dearborn 60
Columbus 57
Bengaluru 52
Chicago 51
Dong Ket 49
Orem 48
Redondo Beach 45
Lappeenranta 43
Nanjing 43
San Mateo 42
Florence 36
Da Nang 34
Warsaw 34
London 33
Turin 32
Nuremberg 31
Shanghai 31
Frankfurt am Main 30
Tokyo 30
Figino 29
San Diego 28
Boardman 26
Guangzhou 26
Naples 26
Abidjan 24
Brussels 24
Montreal 24
San Francisco 24
Atlanta 23
Chennai 23
Izmir 23
Brooklyn 22
Istanbul 22
Turku 20
Washington 20
Denver 19
Mexico City 19
Portsmouth 19
Rio de Janeiro 19
Toronto 19
Düsseldorf 18
Amsterdam 17
Boston 17
Nanchang 16
Phoenix 16
Bologna 15
Campinas 15
Haiphong 15
Manchester 15
Mumbai 15
Stockholm 15
Baghdad 14
Bari 14
Charlotte 14
Tashkent 14
Abuja 13
Belo Horizonte 13
Jinan 13
Hebei 12
Pisa 12
Shenyang 12
Amman 11
Totale 12.630
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 357
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 347
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 340
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 327
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 323
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 322
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 321
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 320
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 298
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 281
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 275
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 273
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 263
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 249
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 247
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 246
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 246
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 246
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 244
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 244
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 244
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 240
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 236
IL-6 blockade in the management of non-infectious uveitis 232
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 230
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 225
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 222
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 216
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 214
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 210
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 208
Development and implementation of the AIDA International Registry for patients with Behçet's disease 208
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 206
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 202
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry 196
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 192
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 192
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 189
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 183
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 177
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 177
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 176
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 176
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 172
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 170
Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders 170
Autoinflammatory diseases and the kidney 162
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 162
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 161
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 160
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 159
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe 159
Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study 157
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 155
Comparing biologic options for the management of Behcet's disease-related uveitis 155
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 154
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 154
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 153
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 153
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review 152
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 151
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 150
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 149
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 148
Biotechnological agents for patients with tumor necrosis factor receptor associated periodic syndrome—therapeutic outcome and predictors of response: real-life data from the AIDA Network 145
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 143
Development and implementation of the AIDA international registry for patients with Still's disease 142
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 141
Development and implementation of the international AIDA network spondylarthritis registry 141
Efficacy and safety of adalimumab in pediatric non-infectious non-anterior uveitis: real-life experience from the International AIDA Network Uveitis Registry 141
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 140
Efficacy and safety of abatacept in a patient with rheumatoid arthritis and concomitant Staphylococcus aureus osteomyelitis 139
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry 138
Biologic therapies and small molecules for the management of non-infectious scleritis: a narrative review 137
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 136
Power and spectral Doppler ultrasound in suspected active sacroiliitis: A comparison with magnetic resonance imaging as gold standard 136
The role of biologic agents in the management of pediatric-onset noninfectious posterior scleritis 131
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 131
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 130
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries 130
Polidistrectual videocapillaroscopic evaluation in a patient with prolidase deficiency 130
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 129
Efficacy and safety of tocilizumab in adult-onset Still's disease: real-life experience from the international AIDA registry 128
The current status of biological treatment for uveitis 127
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 126
Musculoskeletal manifestations in hereditary periodic fever syndromes 125
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: a multicenter study from the AIDA Network PFAPA syndrome registry 124
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 121
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 119
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 119
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 116
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry 115
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry 113
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 111
Imaging findings in patients with axial spondyloarthritis presenting with recurrent fever attacks: data from the international AIDA network spondyloarthritis registry 111
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 110
Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 106
New potential weapons for refractory scleritis in the era of targeted therapy 104
The autoinflammatory diseases alliance registry of monogenic autoinflammatory diseases 100
Empowering patients in the therapeutic decision-making process: a glance into Behçet's syndrome 97
Totale 18.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 112 64 55 45 9 36 32 47 78 104 168
2022/2023804 57 71 132 94 57 153 28 63 72 12 37 28
2023/20241.062 39 24 91 56 32 298 302 55 12 18 48 87
2024/20253.577 289 145 354 151 406 209 164 200 272 183 318 886
2025/20269.388 645 1.233 1.057 1.111 1.439 305 1.077 303 330 506 429 953
2026/2027821 452 369 0 0 0 0 0 0 0 0 0 0
Totale 19.863